Diagnostics Blog

By bivda on 27/11/2014 15:36

Today (27 November, 2014) a commission established by the Lancet has reported that liver disease stands out as a glaring exception to the vast improvements made during the past 30 years in health and life expectancy for chronic disorders such as stroke, heart disease and many cancers.

By bivda on 18/11/2014 12:07

Today is European Antibiotics Awareness Day 2014 (EAAD). This International Day of awareness was started in order to educate people about the appropriate use of antibiotics, in the fight against Antimicrobial Resistance (AMR). 

By bivda on 05/08/2014 10:45

Today is Testing Tuesday! And this week we are raising awareness of Hepatitis. (Not heard of TestingTuesday? See here to find out more)

By bivda on 28/07/2014 11:43

Following four years in office, with a solid reputation for representing the scientific community, as well as British universities, David Willetts MP has moved on as Minister for Universities and Science. The work he has undertaken will of course be remembered, and we are still looking forward to working on the Catapult for Precision Medicine brought about by David Willetts.

 The dual role of David “two brains” Willetts has been taken on by two MPs, George Freeman and Greg Clark.

By bivda on 02/07/2014 10:49

Prime Minister David Cameron, has announced a review into antimicrobial resistance, and why so few drugs have been manufactured in recent years. The last major antibiotic was created in 1987.

Jim O’Neill, former Chief Economist at Goldman Sachs, will lead a global panel of experts from science, finance, industry, and global health, aiming to spur the development of a “new generation of antibiotics”. Work will begin in September, with the first £500,000 of the project being funded by the Wellcome Trust.  Mr O’Neill is expected to deliver his recommendations next spring.

By bivda on 18/06/2014 08:46

Today NICE will publish updated guidance on the treatment of Atrial Fibrillation. Although NICE periodically updates all of its guidance to take account of the latest research and best practice, for the first time today the guidance will be accompanied by the publication of a Consensus statement on the use of Novel Oral Anticoagulants (NOACs) drafted by the NICE Implementation Collaborative (NIC). BIVDA has been a member of the NIC Board since its inception as part ofInnovation, Health and Wealth.